| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.66 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |